LEXINGTON, MA, Keros Therapeutics, a company dedicated to the discovery and development of novel therapeutics for neuromuscular diseases, announced a $23 million Series B financing today. Read More
NEW YORK, NY, AbleTo announced today that it had secured a significant investment from Optum Ventures, closing out a recently raised Series D financing. Read More